Invezz

Best 3 REITs to own for reliable passive income in 2026

Best 3 REITs to own for reliable passive income in 2026
Wajeeh Khan
24 Jul 2026, 14:10 PM

powered by

Invezz
Realty Income (O)

Buy O. The thesis is simple: monthly net-lease cash flow with strong coverage—99% occupancy and a 103% rent recapture rate, plus AFFO up 7% YoY and a long record of dividend hikes (132 since 1994). The Apollo partnership and raised investment guidance support steady growth, not just yield. At ~$65 with ~5% yield and ~10% upside to ~$72, you’re paid while the market rerates durability.

Key Risk: A sharp rise in tenant credit stress that drives occupancy down and forces dividend cuts.

Healthpeak (DOC)

Buy DOC. The news points to a cleaner income story: Healthpeak moved to a monthly payout (~5.53% yield at ~$21.62) and is monetizing the Janus Living IPO while keeping an 82% stake. Operational momentum is improving (senior housing same-store cash NOI +14%) and guidance was raised to $1.71–$1.75, with repurchases supporting per-share value.

Key Risk: Restructuring fails—senior housing demand/NOI deteriorates faster than expected, making the monthly dividend unsustainable.

  • Real estate investment trusts often offer secure durable cash flows.
  • Realty Income, STAG, and Healthpeak are particularly attractive in 2026.
  • Here's what the three have in store for investors this year.

As central bank policy stabilizes and real estate valuations recalibrate, income-focused investors are increasingly looking toward real estate investment trusts (REITs) to secure durable cash flows.

However, capturing reliable passive income in today's market requires looking beyond raw yield – it demands balance sheet strength, high portfolio occupancy, and clear distribution visibility.

Whether anchoring a portfolio with monthly net-lease payouts, riding structural industrial tailwinds, or tapping into healthcare real estate restructuring, selective allocations can provide both inflation defense and reliable yield.

Here are three top REITs positioning themselves as standout income engines for 2026.

Realty Income: the net-lease anchor

Realty Income remains the foundational allocation for monthly cash flow-seeking investors.

Hovering around $65 currently, with a market cap of over $60 billion, the company pays a healthy dividend yield of 5.01% at writing, underpinned by a June payout hike to $0.271 a share – marking 132 dividend hikes since its 1994 public debut.

Q1 Adjusted Funds From Operations (AFFO) climbed 7% year-over-year to $1.13 a share on $1.55 billion in revenue, driven by 99% portfolio occupancy and a 103% rent recapture rate.

Realty’s management expanded full-year investment volume guidance to $9.5 billion – reinforced by a $1.0 billion strategic partnership with Apollo.

All in all, cash flow durability and disciplined capital deployment are why Wall Street analysts rate it at Overweight currently, with price targets going as high as $72, indicating about a 10% upside from here.

STAG Industrial: logistics growth with adjusted cadence

STAG Industrial provides focused exposure to single-tenant industrial real estate, though investors should account for its January 2026 operational transition from monthly to quarterly dividend distributions.

At about $40 per share, STAG yields roughly 3.45% via its $0.3875 quarterly payout.

Underlying fundamental momentum remains robust: fourth-quarter 2025 revenue expanded 11% year-over-year to $220.9 million, generating an 8% increase in Core FFO to $0.66 per share.

Portfolio occupancy held strong at 96.4%, accompanied by a 24% full-year cash rent change.

With 69% of 2026 leasing already secured at a 20% cash rent spread and a $3.6 billion deal pipeline, STAG offers high-quality dividend protection.

That said, Wall Street currently rates STAG stock at Hold only, with the mean price target of nearly $42.

Healthpeak Properties: healthcare restructuring unlocks value

Healthpeak Properties presents a compelling yield strategy following its transition to a monthly payout structure of $0.10 per share, delivering a 5.53% yield at $21.62.

The primary catalyst stems from the Janus Living IPO, which netted approximately $880 million in capital while allowing Healthpeak to retain an 82% equity stake in the $6.9 billion entity.

First-quarter 2026 operational metrics outperformed expectations, as GAAP EPS of $0.28 easily beat consensus estimates and senior housing same-store cash NOI expanded 14%.

Healthpeak’s management raised full-year adjusted FFO guidance to $1.71–$1.75 per share, reinforcing dividend safety alongside an active share repurchase program.

Wall Street currently rates DOC at Overweight with price targets going as high as $29.